Stock Market News1 month Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks
The FDA’s nod to IONS’ Tryngolza makes it the first approved treatment for FCS. It is also the company’s first wholly-owned drug to receive marketing approval.
XThe FDA’s nod to IONS’ Tryngolza makes it the first approved treatment for FCS. It is also the company’s first wholly-owned drug to receive marketing approval.
X